FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+18.86%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$16.1B
AUM Growth
+$16.1B
(+14%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
31.86%
Holding
165
New
37
Increased
28
Reduced
33
Closed
28
Top Buys
| 1 |
Aramark
ARMK
|
$424M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$362M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$351M |
| 4 |
RTX Corp
RTX
|
$325M |
| 5 |
Broadcom
AVGO
|
$273M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$498M |
| 2 |
AbbVie
ABBV
|
$332M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$299M |
| 4 |
Palo Alto Networks
PANW
|
$217M |
| 5 |
Bristol-Myers Squibb
BMY
|
$217M |
Sector Composition
| 1 | Healthcare | 39.5% |
| 2 | Communication Services | 13.65% |
| 3 | Financials | 10.37% |
| 4 | Technology | 10.17% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$32.4B
| $724M | 4.36% | 4,043,506 +516,870 | +15% | +$92.6M |
|
2
Alphabet (Google) Class C
GOOG
$2.58T
| $633M | 3.8% | 361,094 -1,535 | -0.4% | -$2.69M |
|
3
T-Mobile US
TMUS
$284B
| $533M | 3.2% | 3,949,181 +312,200 | +9% | +$42.1M |
|
4
Thermo Fisher Scientific
TMO
$186B
| $519M | 3.12% | 1,114,248 +18,670 | +2% | +$8.7M |
|
5
Visa
V
$683B
| $487M | 2.93% | 2,228,104 +511,400 | +30% | +$112M |
|
6
Aon
AON
$79.1B
| $480M | 2.89% | 2,271,514 +515,170 | +29% | +$109M |
|
7
Boston Scientific
BSX
$156B
| $476M | 2.86% | 13,238,319 +4,962,400 | +60% | +$178M |
|
8
Fidelity National Information Services
FIS
$36.5B
| $445M | 2.68% | 3,149,118 -13,740 | -0.4% | -$1.94M |
|
|
9
Aramark
ARMK
$10.3B
| $424M | 2.55% | +11,023,949 | New | +$424M |
|
10
Centene
CNC
$14.3B
| $411M | 2.47% | 6,850,000 -200,000 | -3% | -$12M |
|
11
Elevance Health
ELV
$71.8B
| $409M | 2.46% | 1,275,000 | – | – |
|
12
Microsoft
MSFT
$3.77T
| $391M | 2.35% | 1,758,168 +217,190 | +14% | +$48.3M |
|
13
Wabtec
WAB
$33.1B
| $366M | 2.2% | 4,997,371 -442,180 | -8% | -$32.4M |
|
|
XLNX
14
DELISTED
Xilinx Inc
XLNX
| $362M | 2.18% | +2,556,000 | New | +$362M |
|
15
Charter Communications
CHTR
$36.3B
| $362M | 2.18% | 546,931 -186,260 | -25% | -$123M |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $351M | 2.11% | +2,246,900 | New | +$351M |
|
17
New York Times
NYT
$9.74B
| $339M | 2.04% | 6,545,329 -560,713 | -8% | -$29M |
|
|
XLRN
18
DELISTED
Acceleron Pharma Inc.
XLRN
| $333M | 2% | 2,600,000 | – | – |
|
|
19
RTX Corp
RTX
$212B
| $325M | 1.95% | +4,542,306 | New | +$325M |
|
20
Meta Platforms (Facebook)
META
$1.86T
| $315M | 1.9% | 1,154,005 -388,040 | -25% | -$106M |
|
21
Salesforce
CRM
$245B
| $314M | 1.89% | 1,409,045 +710,730 | +102% | +$158M |
|
|
TIF
22
DELISTED
Tiffany & Co.
TIF
| $301M | 1.81% | 2,287,000 | – | – |
|
23
Sherwin-Williams
SHW
$91.2B
| $286M | 1.72% | 389,366 -16,420 | -4% | -$12.1M |
|
24
Iovance Biotherapeutics
IOVA
$807M
| $278M | 1.67% | 6,000,000 +45,000 | +0.8% | +$2.09M |
|
25
Fate Therapeutics
FATE
$120M
| $273M | 1.64% | 3,000,000 -125,000 | -4% | -$11.4M |
|